Apellis Pharmaceuticals
Price & Volume
Stats
See more52W Range | $3.47-$41.14 |
Market Cap | $5.2B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $1.1B |
Revenue Growth (YoY) | 60.9% |
Gross Profit (12 Mos) | $710.4M |
Diluted EPS | $1.07 |
News
See moreYahoo Finance • 17 hours ago
Alps Group Receives Minimum Bid Price Deficiency Notice From Nasdaq
Yahoo Finance • 7 days ago
Biogen Completes Acquisition of Apellis Pharmaceuticals
Yahoo Finance • 13 days ago
Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600
Yahoo Finance • 15 days ago
Halper Sadeh LLC is Investigating Whether SLNO, APLS, HLX are Obtaining Fair Deals for their Shareholders
About
CEO | Dr. Cedric Francois M.D., Ph.D. |
CFO | Mr. Timothy E. Sullivan |
Address | 100 Fifth Avenue, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 733 |